Key result
Statin-treated CAD linked to slightly lower LDL-C/apoB ratio than controls without disease.
Case-Control (n=214)
Answers are grounded in this paper and cite their sources.
Examines LDL-C/apoB ratio in statin-treated patients, highlighting its role in CAD assessment.
Low density lipoproteins (LDLs) are heterogeneous aggregations of molecules of different particle sizes, and small-size LDLs are more potent risk factors for atherosclerosis. We examined the qualitative characteristics of LDLs in patients with stable coronary artery disease (CAD) receiving statin therapy. LDL-particle size was estimated based on the LDL-cholesterol/apolipoprotein B ratio (LDL-C/apoB) in 214 age-adjusted men receiving statin therapy. The LDL-C/apoB ratio was significantly lower in the CAD (+) group (n = 107) than in the CAD (-) group (n = 107) (median, 1.17 versus 1.19, P = 0.0095). LDL-C/apoB was significantly lower in patients with serum TG ≥ 150 mg/dL than in those with serum TG < 150 mg/dL, and in patients with serum HDL-C < 40 mg/dL than in those with serum HDL-C ≥ 40 mg/dL (1.06 versus 1.18, P = 0.012; 1.08 versus 1.22, P = 0.0023). Stepwise logistic regression analysis revealed that elevated serum TG was an independent predictor for smaller sizes of LDLs, both in the overall subjects (β : -0.165, P = 0.02) as well as in the subset with serum LDL-C < 100 mg/dL (β : -0.252, P = 0.011). This study demonstrated that not only the absolute serum LDL-C level, but also the qualitative characteristics of LDL may be monitored for secondary prevention of CAD. Such monitoring is particularly important in patients with elevated serum TG levels, which is associated with smaller sizes of LDL-particles.
No takes yet. Share an insight, caveat, or question.
Tani et al. (2011) conducted a case-control in Coronary artery disease (CAD) (n=214). Presence of stable coronary artery disease vs. Absence of coronary artery disease was evaluated on LDL-cholesterol/apolipoprotein B ratio (LDL-C/apoB) (p=0.0095). The median LDL-cholesterol/apolipoprotein B ratio was lower in statin-treated men with coronary artery disease than in those without.
Synapse has enriched 10 related papers. Consider them for comparative context: